# Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer

> **NCT01088347** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 9 (actual)

## Conditions studied

- Advanced Cervical Cancer

## Interventions

- **DRUG:** mapatumumab
- **DRUG:** cisplatin
- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT01088347
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2024-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01088347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01088347, "Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01088347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*